Skip to main content

Table 2 Data on mRNA levels of osteoclast specific genes and RANK/RANKL/OPG genes in OP and OA

From: The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues

Gene symbol

Gene name

OP (n = 23)

OA (n = 31)

OP/OAa

p valueb

Osteoclast specific genes

OSCAR

Osteoclast associated immunoglobulin-like receptor

0.574(0.345;0.854)

1.002(0.732;1.339)

0.54

0.002*

ITGB3

β3 integrin

0.241(0.074;0.586)

0.285(0.143;0.994)

0.85

0.231

CTSK

Cathepsin K

0.288(0.121;1.109)

0.263(0.136;0.555)

1.10

0.786

ACP5

Tartrate resistant acid phosphatase (TRAP)

0.270(.128;1.011)

0.147(0.073;0.259)

1.84

0.049*

CALCR

Calcitonin receptor

0.223(0.138;0.644)

0.860(0.482;1.562)

0.26

< 0.0005**

RANK/RANKL/OPG genes

TNFRSF11A

Receptor activator of nuclear factor κB (RANK)

1.580(0.687;3.939)

0.573(0.355;1.038)

2.76

0.002*

TNFSF11

Receptor activator of nuclear factor κB ligand (RANKL)

0.528(0.076;1.038)

0.091(0.027;0.253)

5.80

< 0.0005**

TNFRSF11B

Osteoprotegerin (OPG)

0.699(0.410;0.914)

0.776(0.308;1.615)

0.90

0.681

TNFSF11/TNFRSF11A

RANKL/RANK

0.241(0.083;0.928)

0.140(0.064;0.271)

1.72

0.076

TNFSF11/TNFRSF11B

RANKL/OPG

0.448(0.295;1.601)

0.112(0.075;0.193)

4.00

< 0.0005**

  1. Values are medians(25th;75th percentile). All mRNA values were normalized to the geometric mean of GAPDH and RPLP0 mRNA.
  2. aGene expression ratio of medians in osteoporotic (OP) versus osteoarthritic (OA) patients.
  3. bComparisons were assessed by the Mann-Whitney U test. *p < 0.05, **p < 0.001.